Semiconductor company Quantum-Si said it completed its business combination with HighCape Capital Acquisition. The business combination and concurrent private placement, which were approved by HighCape’s stockholders June 9, provide over $500 million to fund the further development and planned commercialization of the company’s single-molecule, semiconductor chip-based protein sequencing and genomics technology. The transaction was supported by a $425 million PIPE at $10 per share.
Quantum-Si Class A common stock and warrants begin trading on the Nasdaq today under QSI and QSIAW, respectively.
The final exchange ratio for shares of Quantum-Si capital stock for common stock of the combined company was 0.7975. Each share of HighCape Class A common stock and HighCape Class B common stock became one share of the combined company’s Class A common stock. Read more.
